Latest News

BeiGene and EUSA Pharma Announce China NMPA Approval of QARZIBA® (Dinutuximab Beta) for Patients with High-Risk Neuroblastoma

17/08/2021

Read More …

EUSA Pharma Announces Appointment of Carsten Thiel as New Chief Executive Officer

30/03/2021

Read More …

SYLVANT® (siltuximab) Recommended by the National Comprehensive Cancer Network® (NCCN®) as the Preferred Treatment Option for Patients with Idiopathic Multicentric…

25/02/2021

Read More …
All News